CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003 (Q57180219)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Caroline Sabin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

W Stöhr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Hill

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

B Gazzard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

J Walsh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

R Gilson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

P Easterbrook

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

M Fisher

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dt Dunn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ma Johnson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Vc Delpech

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

An Phillips

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

UK CHIC Study

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

135-141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Findings from the first national clinical audit of treatment for people with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Findings from the British HIV Association's national clinical audit of first-line antiretroviral therapy and survey of treatment practice and maternity care, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Newly diagnosed HIV infections: review in UK and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00443.X

10.1111/J.1468-1293.2007.00443.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461856%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference